MED20: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker
MED20: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker
MED20 (microRNA-20) is a non-coding RNA molecule that plays a critical role in various cellular processes. It is a key regulator of cell proliferation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the key functions of MED20 is its ability to target specific mRNAs for degradation. This process is known as post-transcriptional modification (PTM), and it involves the removal of certain RNA molecules that are no longer needed in the cell. In addition to its role in regulating gene expression, MED20 has also been shown to play a key role in regulating the stability of RNA molecules in the cell.
Recent studies have identified MED20 as a potential drug target for a number of different diseases. For example, researchers have found that high levels of MED20 are associated with poor prognosis in breast cancer, and that inhibiting MED20 may be an effective way to improve treatment outcomes. Similarly, MED20 has been shown to be involved in the development and progression of neurodegenerative diseases, and may be a useful target for new treatments.
In addition to its potential as a drug target, MED20 is also a potential biomarker for a number of different diseases. For example, studies have shown that MED20 levels are often elevated in the brains of individuals with Alzheimer's disease, and that inhibiting MED20 may be a promising way to develop new treatments for this debilitating condition.
While more research is needed to fully understand the role of MED20 in disease, it is clear that it is an important player in the regulation of cellular processes. Its potential as a drug target and biomarker make it an attractive target for future research and development.
Protein Name: Mediator Complex Subunit 20
Functions: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors
More Common Targets
MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C | MEF2C-AS1 | MEF2C-AS2 | MEF2D | MEFV | MEG3 | MEG8 | MEG9 | MEGF10 | MEGF11 | MEGF6 | MEGF8 | MEGF9 | MEI1 | MEI4 | MEIG1 | MEIKIN | MEIOB | MEIOC | MEIOSIN | MEIS1 | MEIS1-AS2 | MEIS1-AS3 | MEIS2 | MEIS3 | MEIS3P1 | MEIS3P2 | Melanin | Melanin-concentrating hormone (MCH) receptor | Melanocortin receptor | Melanoma-Associated Antigen | Melatonin receptor | MELK | MELTF | MELTF-AS1 | Membrane-Bound Protein Tyrosine Phosphatases (rPTPs) | Membrane-spanning 4-domains subfamily A member 4A | MEMO1 | MEMO1P1 | MEMO1P4 | MEMO1P5 | MEN1 | MEOX1 | MEOX2 | MEP1A | MEP1AP2 | MEP1AP4 | MEP1B | MEPCE | MEPE | MERTK | MESD | MESP1 | MESP2 | MEST | MESTIT1 | MESTP3 | MESTP4 | MET | Metabotropic glutamate (mGluR) receptor | Metallothionein | METAP1 | METAP1D | METAP2 | Metaxin complex | Methionine adenosyltransferase | Methionine adenosyltransferase II | Methionyl aminopeptidase | Methylcytosine dioxygenase (TET) | METRN | METRNL | METTL1 | METTL13 | METTL14 | METTL15 | METTL15P1 | METTL15P2 | METTL16